At the 2019 BIO Investor Forum, held at Westin St.
Francis Hotel near San Francisco’s Union Square, Haystack was featured, and chosen
as a “Buzz of BIO finalist”. The BIF was attended by more than 1,000 inventors and
investors, with a strong emphasis on one-on-one partnering meetings, which paired
the company with prospective partners and sources of funding.
Haystack’s Chief Business Officer, Dr. Jonathan Burbaum, presented the company
to investors on Tuesday, October 23.
Haystack’s Chief Executive Officer, Dr. Eddie Ray Watts was interviewed later in
the day by Proactive Investors, a web-based portal that enables companies and
investors to connect intelligently. You can view the company’s coverage here.
Haystack was selected by Connect as part of
their Cool Companies 2020. Cool Companies is an annual capital
program designed to match the best technology and life sciences
startups ready to raise Series A — […]